MITOMYCIN

MITOMYCIN was reported 3659 times

MITOMYCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NPM1 GENE MUTATION 11 0.7857
1 CONJUNCTIVAL FILTERING BLEB LEAK 23 0.6053
2 BLEBITIS 23 0.5227
3 GLAUCOMA DRAINAGE DEVICE EXPOSURE 4 0.5000
4 ANTERIOR CHAMBER ANGLE NEOVASCULARISATION 2 0.4000
5 PENIS CARCINOMA RECURRENT 2 0.4000
6 SCLERAL THINNING 36 0.3396
7 ALEXANDER DISEASE 2 0.3333
8 SCLEROMALACIA 20 0.2899
9 CHEMICAL CYSTITIS 10 0.2564
10 BLADDER NECROSIS 14 0.2188
11 POSTOPERATIVE HETEROTOPIC CALCIFICATION 5 0.2000
12 ANTERIOR CHAMBER PIGMENTATION 4 0.2000
13 CONJUNCTIVAL BLEB 10 0.1852
14 CORECTOPIA 2 0.1538
15 CONJUNCTIVAL EROSION 17 0.1405
16 CHIMERISM 11 0.1236
17 STAPHYLOMA 3 0.0968
18 URINARY TRACT TOXICITY 4 0.0909
19 BLADDER PERFORATION 34 0.0879
20 HEPATIC ARTERY OCCLUSION 7 0.0824
21 UVEITIC GLAUCOMA 3 0.0789
22 AMNIOTIC MEMBRANE GRAFT 2 0.0769
23 NECROTISING SCLERITIS 11 0.0759
24 HYPOTONY MACULOPATHY 3 0.0732
25 HYPOTONY OF EYE 29 0.0690
26 PULMONARY VENO-OCCLUSIVE DISEASE 46 0.0657
27 BRONCHIOLITIS OBLITERANS SYNDROME 11 0.0629
28 HEPATIC ARTERY STENOSIS 8 0.0615
29 LIMBAL STEM CELL DEFICIENCY 5 0.0610
30 PULMONARY CAPILLARY HAEMANGIOMATOSIS 3 0.0545
31 INSTILLATION SITE HAEMORRHAGE 2 0.0513
32 BLADDER FIBROSIS 2 0.0500
33 BILE DUCT NECROSIS 3 0.0492
34 CORNEAL EPITHELIAL MICROCYSTS 8 0.0479
35 URETERIC STENOSIS 38 0.0474
36 POST EMBOLISATION SYNDROME 5 0.0435
37 INSTILLATION SITE INFECTION 2 0.0426
38 PIGMENT DISPERSION SYNDROME 4 0.0421
39 TREATMENT RELATED SECONDARY MALIGNANCY 8 0.0394
40 CARDIAC CIRRHOSIS 4 0.0388
41 ADMINISTRATION SITE EXTRAVASATION 38 0.0380
42 IRIS HYPOPIGMENTATION 4 0.0374
43 NEUROTROPHIC KERATOPATHY 2 0.0370
44 CHOROIDAL HAEMORRHAGE 7 0.0363
45 PENILE NECROSIS 4 0.0360
46 SCROTAL ULCER 9 0.0345
47 ISCHAEMIC ULCER 2 0.0333
48 DIAPHRAGM MUSCLE WEAKNESS 5 0.0316
49 PELVI-URETERIC OBSTRUCTION 7 0.0302
50 RENAL SCAN ABNORMAL 2 0.0278
51 BILIARY FISTULA 4 0.0261
52 BLOOD CHROMOGRANIN A INCREASED 12 0.0261
53 EYE INFECTION STAPHYLOCOCCAL 7 0.0242
54 RADIATION SKIN INJURY 28 0.0241
55 ANAL INJURY 4 0.0231
56 GASTRIC ANTRAL VASCULAR ECTASIA 12 0.0227
57 FLAT ANTERIOR CHAMBER OF EYE 4 0.0223
58 SPINAL CORD ISCHAEMIA 3 0.0197
59 BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT 2 0.0196
60 ACUTE PROMYELOCYTIC LEUKAEMIA 20 0.0195
61 IRIS ATROPHY 4 0.0193
62 POST PROCEDURAL VOMITING 2 0.0192
63 HYPHAEMA 10 0.0192
64 HEPATIC NEOPLASM MALIGNANT RECURRENT 2 0.0189
65 RESPIRATORY MONILIASIS 5 0.0187
66 CONJUNCTIVAL DISORDER 7 0.0184
67 RENAL NECROSIS 4 0.0183
68 CHOROIDAL DETACHMENT 10 0.0180
69 PRODUCT INTOLERANCE 4 0.0180
70 CARCINOID CRISIS 4 0.0177
71 POST PROCEDURAL NAUSEA 2 0.0177
72 DYSTROPHIC CALCIFICATION 2 0.0174
73 DYSAESTHESIA PHARYNX 3 0.0171
74 SCROTAL DISORDER 5 0.0166
75 SCLEROSING ENCAPSULATING PERITONITIS 3 0.0163
76 URETHRAL STENOSIS 11 0.0161
77 IRIS TRANSILLUMINATION DEFECT 3 0.0160
78 ADMINISTRATION SITE DISCOMFORT 3 0.0159
79 ANASTOMOTIC HAEMORRHAGE 3 0.0158
80 IRIDOCELE 2 0.0154
81 URINARY TRACT DISCOMFORT 7 0.0152
82 CORNEAL DEFECT 2 0.0152
83 ARTERIAL SPASM 3 0.0152
84 CORNEAL EROSION 8 0.0148
85 CONJUNCTIVAL ULCER 2 0.0145
86 BILOMA 2 0.0142
87 DISORDER OF ORBIT 2 0.0139
88 CORNEAL EPITHELIUM DEFECT 8 0.0138
89 RENAL CANCER RECURRENT 2 0.0136
90 ADAMS-STOKES SYNDROME 2 0.0130
91 BLADDER SPASM 24 0.0128
92 CONTRACTED BLADDER 2 0.0124
93 CORNEAL DECOMPENSATION 2 0.0124
94 ADENOCARCINOMA OF THE CERVIX 2 0.0123
95 LIVER SCAN ABNORMAL 2 0.0123
96 ENDOMETRIAL CANCER STAGE I 2 0.0120
97 ENCAPSULATING PERITONEAL SCLEROSIS 2 0.0112
98 SCLERAL DISORDER 3 0.0111
99 GASTRIC STENOSIS 2 0.0109
100 RETINAL TOXICITY 11 0.0107
101 OCULAR SURFACE DISEASE 3 0.0107
102 HAEMOLYTIC URAEMIC SYNDROME 24 0.0103
103 CHORIORETINAL DISORDER 2 0.0102
104 CHEMICAL PERITONITIS 2 0.0101
105 PUPILLARY DISORDER 6 0.0099
106 ANAL SQUAMOUS CELL CARCINOMA 3 0.0097
107 KERATITIS FUNGAL 2 0.0096
108 CORNEAL GRAFT REJECTION 2 0.0095
109 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 2 0.0094
110 PENILE OEDEMA 3 0.0092
111 GENITAL DISCOMFORT 5 0.0090
112 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 2 0.0087
113 ANASTOMOTIC LEAK 6 0.0086
114 LOWER URINARY TRACT SYMPTOMS 3 0.0083
115 CORNEAL DEGENERATION 2 0.0083
116 OVARIAN CANCER METASTATIC 7 0.0082
117 CYSTITIS NONINFECTIVE 11 0.0082
118 PENILE ERYTHEMA 3 0.0080
119 CORNEAL SCAR 4 0.0080
120 POST PROCEDURAL DIARRHOEA 4 0.0079
121 BOVINE TUBERCULOSIS 3 0.0078
122 NECROTISING RETINITIS 5 0.0078
123 CORNEAL THINNING 2 0.0078
124 BLOOD ALKALINE PHOSPHATASE ABNORMAL 7 0.0078
125 INSTILLATION SITE DISCHARGE 2 0.0076
126 PANNICULITIS 18 0.0074
127 STEROID DIABETES 11 0.0073
128 URETERIC OBSTRUCTION 10 0.0073
129 PENILE DISCHARGE 2 0.0072
130 VASCULAR STENT STENOSIS 3 0.0071
131 DIAPHRAGMATIC PARALYSIS 4 0.0067
132 GASTRIC PERFORATION 18 0.0066
133 NECROSIS ISCHAEMIC 3 0.0065
134 BLADDER INJURY 2 0.0063
135 ACTIVITIES OF DAILY LIVING DECREASED 4 0.0063
136 CORNEAL OEDEMA 14 0.0062
137 ANAL CANCER 6 0.0062
138 ACUTE MYELOID LEUKAEMIA RECURRENT 13 0.0060
139 GENITAL ERYTHEMA 3 0.0060
140 DERMATITIS INFECTED 3 0.0060
141 METASTASES TO SKIN 6 0.0058
142 SCROTAL OEDEMA 4 0.0056
143 PERINEAL PAIN 4 0.0056
144 IRIS DISORDER 3 0.0056
145 SCROTAL PAIN 3 0.0056
146 AXILLARY VEIN THROMBOSIS 2 0.0054
147 POSTOPERATIVE ILEUS 3 0.0053
148 HEPATIC INFARCTION 2 0.0053
149 ASPARTATE AMINOTRANSFERASE ABNORMAL 8 0.0052
150 HERPES SIMPLEX REACTIVATION 2 0.0052
151 GENITAL ULCERATION 4 0.0052
152 ENDOPHTHALMITIS 31 0.0052
153 RETINAL VASCULAR DISORDER 3 0.0051
154 FLANK PAIN 47 0.0050
155 NEOPLASM RECURRENCE 17 0.0050
156 DEVICE RELATED SEPSIS 10 0.0050
157 CORNEAL PERFORATION 3 0.0048
158 POSTOPERATIVE WOUND COMPLICATION 6 0.0047
159 OEDEMA GENITAL 3 0.0047
160 LOCALISED INTRAABDOMINAL FLUID COLLECTION 2 0.0044
161 BLOOD IMMUNOGLOBULIN G DECREASED 11 0.0044
162 CORNEAL OPACITY 6 0.0044
163 BILIARY SEPSIS 2 0.0043
164 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 2 0.0043
165 PANCREATIC CARCINOMA METASTATIC 12 0.0042
166 EXTRAVASATION 17 0.0041
167 ESCHAR 3 0.0041
168 CORNEAL DISORDER 9 0.0041
169 MARKEDLY REDUCED DIETARY INTAKE 2 0.0041
170 SKIN NECROSIS 21 0.0040
171 CORNEAL DEPOSITS 3 0.0040
172 ARTERIOSPASM CORONARY 16 0.0040
173 ENTEROVESICAL FISTULA 3 0.0040
174 IRIS ADHESIONS 2 0.0039
175 RENAL HAEMATOMA 2 0.0039
176 ASEPTIC NECROSIS BONE 3 0.0038
177 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 3 0.0038
178 INTRAOCULAR PRESSURE DECREASED 2 0.0038
179 TUMOUR NECROSIS 4 0.0038
180 ANAL STENOSIS 2 0.0038
181 SCLERITIS 6 0.0037
182 CYSTOID MACULAR OEDEMA 7 0.0037
183 LIVER ABSCESS 12 0.0037
184 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 3 0.0037
185 BALANOPOSTHITIS 3 0.0036
186 OCULAR TOXICITY 4 0.0036
187 FUNGAL SEPSIS 3 0.0036
188 METASTASES TO SPINE 12 0.0036
189 BLADDER NEOPLASM 6 0.0035
190 MALIGNANT HYPERTENSION 3 0.0035
191 BLADDER TRANSITIONAL CELL CARCINOMA 5 0.0035
192 IRIDOCYCLITIS 11 0.0035
193 EYE ULCER 2 0.0035
194 TREATMENT DELAYED 6 0.0035
195 GENITAL BURNING SENSATION 3 0.0035
196 VASOCONSTRICTION 3 0.0034
197 DYSURIA 126 0.0034
198 ABDOMINAL SEPSIS 3 0.0034
199 SUPERINFECTION 5 0.0033
200 ALANINE AMINOTRANSFERASE ABNORMAL 7 0.0033
201 FAT NECROSIS 2 0.0033
202 OVARIAN DISORDER 3 0.0032
203 PERNICIOUS ANAEMIA 2 0.0032
204 FOREIGN BODY IN EYE 3 0.0031
205 THROMBOTIC THROMBOCYTOPENIC PURPURA 11 0.0031
206 OVARIAN CANCER RECURRENT 5 0.0031
207 MACULOPATHY 11 0.0031
208 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
209 CATHETER RELATED INFECTION 3 0.0030
210 CHOLANGITIS SCLEROSING 6 0.0029
211 CACHEXIA 15 0.0029
212 GENITAL SWELLING 2 0.0029
213 LYMPHANGIOSIS CARCINOMATOSA 3 0.0029
214 PAINFUL DEFAECATION 2 0.0029
215 HYPOPERFUSION 3 0.0029
216 PELVIC FLUID COLLECTION 2 0.0028
217 BLADDER PAIN 9 0.0028
218 RADIATION INJURY 3 0.0028
219 HYDROCELE 3 0.0028
220 MYCOBACTERIUM ABSCESSUS INFECTION 2 0.0028
221 PROTEUS INFECTION 2 0.0028
222 CARDIAC ENZYMES INCREASED 2 0.0028
223 THROMBOTIC MICROANGIOPATHY 27 0.0028
224 SOFT TISSUE DISORDER 3 0.0027
225 GASTROINTESTINAL TOXICITY 13 0.0027
226 PERIPHERAL VENOUS DISEASE 11 0.0027
227 HYDRONEPHROSIS 20 0.0027
228 CARDIAC INFECTION 2 0.0027
229 DIFFUSE ALVEOLAR DAMAGE 3 0.0026
230 PERIPHERAL EMBOLISM 3 0.0026
231 RESTRICTIVE PULMONARY DISEASE 3 0.0026
232 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 2 0.0025
233 HAEMATURIA 87 0.0025
234 INSTILLATION SITE IRRITATION 3 0.0025
235 OPHTHALMOPLEGIA 4 0.0025
236 GENE MUTATION 5 0.0025
237 BILE DUCT STENOSIS 3 0.0025
238 CHOROIDAL EFFUSION 2 0.0025
239 PENILE HAEMORRHAGE 2 0.0025
240 MICTURITION URGENCY 28 0.0024
241 RENAL ABSCESS 2 0.0024
242 CATHETER SITE HAEMORRHAGE 6 0.0024
243 RECALL PHENOMENON 2 0.0024
244 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 3 0.0024
245 METASTASES TO PERITONEUM 6 0.0024
246 URINARY BLADDER HAEMORRHAGE 5 0.0024
247 BLOOD BILIRUBIN ABNORMAL 3 0.0023
248 FEMALE GENITAL TRACT FISTULA 4 0.0023
249 BLOOD CULTURE POSITIVE 7 0.0023
250 CD4 LYMPHOCYTES DECREASED 5 0.0023
251 OBSTRUCTION GASTRIC 3 0.0023
252 TRANSITIONAL CELL CARCINOMA 3 0.0023
253 RETINAL DEGENERATION 3 0.0023
254 FIBROSIS 7 0.0023
255 CARDIAC OUTPUT DECREASED 2 0.0023
256 COMPRESSION FRACTURE 12 0.0022
257 STRESS CARDIOMYOPATHY 13 0.0022
258 METASTASES TO LIVER 39 0.0022
259 MUCOSAL INFLAMMATION 58 0.0022
260 HAEMATOTOXICITY 21 0.0022
261 PROCTITIS 6 0.0021
262 CULTURE URINE POSITIVE 3 0.0021
263 HEPATIC NECROSIS 8 0.0021
264 PNEUMATOSIS INTESTINALIS 6 0.0021
265 GENITAL RASH 3 0.0021
266 NEUTROPENIC INFECTION 2 0.0021
267 HYPOREFLEXIA 4 0.0021
268 TUMOUR MARKER INCREASED 10 0.0021
269 ONCOLOGIC COMPLICATION 2 0.0021
270 LYMPHADENECTOMY 2 0.0020
271 BONE MARROW DEPRESSION 2 0.0020
272 PANCREATIC ENZYMES INCREASED 3 0.0020
273 PYURIA 2 0.0020
274 INSTILLATION SITE PAIN 5 0.0020
275 BLADDER CANCER RECURRENT 2 0.0020
276 LYMPHOCYTIC INFILTRATION 2 0.0020
277 NEUTROPENIC COLITIS 4 0.0019
278 GRANULOCYTOPENIA 11 0.0019
279 ONYCHOLYSIS 3 0.0019
280 OEDEMA MUCOSAL 2 0.0019
281 HAEMOGLOBIN ABNORMAL 12 0.0019
282 PANCYTOPENIA 104 0.0019
283 ORCHITIS 2 0.0019
284 PULMONARY TOXICITY 13 0.0018
285 PRODUCT NAME CONFUSION 2 0.0018
286 NEUTROPENIC SEPSIS 13 0.0018
287 PERIRECTAL ABSCESS 2 0.0018
288 LARYNGEAL CANCER 2 0.0018
289 CATHETER SITE DISCHARGE 2 0.0018
290 SKIN TOXICITY 10 0.0018
291 PELVIC ABSCESS 2 0.0017
292 UROSEPSIS 16 0.0017
293 GASTROINTESTINAL NECROSIS 5 0.0017
294 PROCTALGIA 11 0.0017
295 STRIDOR 5 0.0017
296 PNEUMOCYSTIS JIROVECII INFECTION 2 0.0017
297 THERAPY INTERRUPTED 119 0.0017
298 BLOOD PHOSPHORUS DECREASED 6 0.0016
299 DYSAESTHESIA 5 0.0016
300 METASTASES TO CENTRAL NERVOUS SYSTEM 21 0.0016
301 RETINOPATHY 6 0.0016
302 BLADDER DISCOMFORT 2 0.0016
303 SMALL INTESTINAL PERFORATION 3 0.0016
304 VENOOCCLUSIVE DISEASE 4 0.0016
305 BILE DUCT OBSTRUCTION 3 0.0016
306 MALLORY-WEISS SYNDROME 2 0.0016
307 LIP HAEMORRHAGE 2 0.0016
308 LYMPHADENOPATHY MEDIASTINAL 3 0.0016
309 METASTASES TO LUNG 18 0.0016
310 IATROGENIC INJURY 2 0.0016
311 LEUKOPENIA 77 0.0015
312 APLASIA 3 0.0015
313 POLLAKIURIA 63 0.0015
314 PYELONEPHRITIS 13 0.0015
315 METASTASES TO BONE 24 0.0015
316 ULCERATIVE KERATITIS 4 0.0015
317 ILEUS 18 0.0014
318 GUILLAIN-BARRE SYNDROME 7 0.0014
319 BILIARY TRACT DISORDER 2 0.0014
320 ACCIDENTAL EXPOSURE 6 0.0014
321 NECROSIS 8 0.0014
322 MYELITIS TRANSVERSE 2 0.0014
323 PRERENAL FAILURE 2 0.0014
324 NEUTROPHIL COUNT ABNORMAL 4 0.0014
325 TUMOUR HAEMORRHAGE 4 0.0014
326 HYPERTONIC BLADDER 4 0.0014
327 BONE MARROW FAILURE 28 0.0014
328 WRONG PATIENT RECEIVED PRODUCT 4 0.0014
329 IMMUNOSUPPRESSION 12 0.0014
330 POST PROCEDURAL COMPLICATION 26 0.0014
331 URINARY RETENTION 45 0.0013
332 HEPATITIS B 8 0.0013
333 ASTIGMATISM 2 0.0013
334 PROSTATITIS 4 0.0013
335 BLOOD PRESSURE IMMEASURABLE 2 0.0013
336 ISCHAEMIA 6 0.0013
337 CALCULUS URINARY 2 0.0013
338 COAGULATION TIME PROLONGED 2 0.0013
339 PRURITUS GENITAL 3 0.0013
340 COLITIS MICROSCOPIC 6 0.0013
341 COLORECTAL CANCER METASTATIC 3 0.0013
342 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
343 CANDIDIASIS 5 0.0012
344 PRODUCT PACKAGING CONFUSION 3 0.0012
345 RENAL PAIN 13 0.0012
346 AORTIC DISSECTION 5 0.0012
347 RECTAL ABSCESS 2 0.0012
348 COLITIS ISCHAEMIC 8 0.0012
349 UVEITIS 16 0.0012
350 HAEMORRHAGE URINARY TRACT 3 0.0012
351 NEUROPATHY 2 0.0012
352 MYELODYSPLASTIC SYNDROME 17 0.0012
353 PROCEDURAL COMPLICATION 9 0.0012
354 LUNG NEOPLASM 5 0.0012
355 PSEUDOMONAS INFECTION 10 0.0012
356 WOUND COMPLICATION 4 0.0012
357 MILIARIA 2 0.0012
358 KIDNEY FIBROSIS 2 0.0012
359 EXFOLIATIVE RASH 3 0.0011
360 GLOSSITIS 4 0.0011
361 INDURATION 2 0.0011
362 ILEUS PARALYTIC 5 0.0011
363 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
364 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 26 0.0011
365 CARDIOGENIC SHOCK 16 0.0011
366 THERAPY CESSATION 57 0.0011
367 SPINAL PAIN 13 0.0011
368 PULMONARY ARTERIAL HYPERTENSION 16 0.0011
369 CONDUCTION DISORDER 2 0.0011
370 THERAPY PARTIAL RESPONDER 17 0.0011
371 INTESTINAL ISCHAEMIA 6 0.0011
372 FEBRILE NEUTROPENIA 72 0.0011
373 SECOND PRIMARY MALIGNANCY 9 0.0011
374 HYPERTRICHOSIS 2 0.0011
375 HEPATIC FAILURE 32 0.0011
376 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
377 DYSPNOEA AT REST 3 0.0010
378 ARTERIAL THROMBOSIS 2 0.0010
379 FAECES HARD 4 0.0010
380 VISUAL ACUITY REDUCED 34 0.0010
381 HYPERAEMIA 2 0.0010
382 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
383 CARDIOTOXICITY 9 0.0010
384 THROMBOCYTOPENIA 112 0.0010
385 BONE MARROW DISORDER 3 0.0010
386 CYSTITIS HAEMORRHAGIC 4 0.0010
387 OBSTRUCTIVE AIRWAYS DISORDER 11 0.0010
388 EYE INJURY 3 0.0010
389 VULVOVAGINAL PRURITUS 5 0.0010
390 KERATITIS 3 0.0010
391 PENILE PAIN 3 0.0010
392 CHANGE OF BOWEL HABIT 2 0.0010
393 DIASTOLIC DYSFUNCTION 3 0.0010
394 AKINESIA 2 0.0010
395 IMPAIRED SELF-CARE 2 0.0010
396 BACTERIAL INFECTION 18 0.0010
397 LIVEDO RETICULARIS 2 0.0010
398 DERMATITIS 20 0.0010
399 UPPER GASTROINTESTINAL HAEMORRHAGE 16 0.0010
400 BREAST CANCER RECURRENT 3 0.0009
401 TESTICULAR PAIN 3 0.0009
402 OPTIC NEUROPATHY 2 0.0009
403 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
404 RENAL NEOPLASM 2 0.0009
405 PHARYNGOLARYNGEAL PAIN 5 0.0009
406 ENTERITIS 6 0.0009
407 ANAEMIA MACROCYTIC 2 0.0009
408 RADIATION PNEUMONITIS 2 0.0009
409 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
410 ANAL INCONTINENCE 8 0.0009
411 URINARY TRACT DISORDER 4 0.0009
412 CLOSTRIDIAL INFECTION 3 0.0009
413 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
414 LEFT VENTRICULAR FAILURE 3 0.0009
415 INTERSTITIAL LUNG DISEASE 42 0.0009
416 TENDERNESS 9 0.0009
417 MENOPAUSAL SYMPTOMS 2 0.0009
418 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 2 0.0009
419 HICCUPS 7 0.0009
420 ESCHERICHIA BACTERAEMIA 2 0.0008
421 JAUNDICE CHOLESTATIC 3 0.0008
422 PULMONARY INFARCTION 2 0.0008
423 DISEASE PROGRESSION 100 0.0008
424 RETINAL HAEMORRHAGE 6 0.0008
425 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
426 ODYNOPHAGIA 5 0.0008
427 OXYGEN CONSUMPTION INCREASED 2 0.0008
428 FAECAL INCONTINENCE 4 0.0008
429 SCLERODERMA 3 0.0008
430 CYSTITIS 26 0.0008
431 NEUTROPENIA 110 0.0008
432 CHOLANGITIS 5 0.0008
433 ABDOMINAL TENDERNESS 4 0.0008
434 PROTEIN TOTAL DECREASED 3 0.0008
435 BRAIN ABSCESS 2 0.0008
436 WHITE BLOOD CELL COUNT ABNORMAL 5 0.0008
437 INCORRECT ROUTE OF DRUG ADMINISTRATION 28 0.0008
438 INTRAOCULAR PRESSURE INCREASED 10 0.0008
439 MEAN CELL VOLUME INCREASED 2 0.0008
440 HEPATOSPLENOMEGALY 2 0.0008
441 TRISMUS 4 0.0008
442 FAILURE TO THRIVE 4 0.0008
443 VENOUS THROMBOSIS 3 0.0008
444 OESOPHAGEAL CANDIDIASIS 3 0.0008
445 ANORECTAL DISCOMFORT 4 0.0008
446 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
447 HEPATIC STEATOSIS 14 0.0008
448 PERIPHERAL ISCHAEMIA 3 0.0007
449 DRUG TOXICITY 10 0.0007
450 NEPHROTIC SYNDROME 5 0.0007
451 COAGULOPATHY 12 0.0007
452 PULMONARY HYPERTENSION 15 0.0007
453 LARGE INTESTINE PERFORATION 5 0.0007
454 LUNG CONSOLIDATION 2 0.0007
455 ANAL HAEMORRHAGE 2 0.0007
456 RIGHT VENTRICULAR FAILURE 5 0.0007
457 ACUTE PULMONARY OEDEMA 4 0.0007
458 NEPHROPATHY TOXIC 8 0.0007
459 SKIN REACTION 10 0.0007
460 ACUTE MYELOID LEUKAEMIA 11 0.0007
461 BLADDER DISORDER 7 0.0007
462 METASTASIS 5 0.0007
463 MYOCARDITIS 8 0.0007
464 PARAPLEGIA 2 0.0007
465 PRODUCT LABEL CONFUSION 4 0.0007
466 PARONYCHIA 3 0.0007
467 TUMOUR LYSIS SYNDROME 6 0.0007
468 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
469 MALIGNANT NEOPLASM PROGRESSION 69 0.0007
470 MYELOFIBROSIS 2 0.0007
471 VULVOVAGINAL BURNING SENSATION 4 0.0007
472 DYSPAREUNIA 3 0.0007
473 CHRONIC MYELOID LEUKAEMIA 3 0.0006
474 PORTAL HYPERTENSION 2 0.0006
475 INTERCEPTED MEDICATION ERROR 3 0.0006
476 ERYTHEMA MULTIFORME 6 0.0006
477 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
478 STAPHYLOCOCCAL INFECTION 21 0.0006
479 NEOPLASM PROGRESSION 22 0.0006
480 ULCER 10 0.0006
481 CUSHINGOID 2 0.0006
482 OCCUPATIONAL EXPOSURE TO PRODUCT 4 0.0006
483 ENTEROCOCCAL INFECTION 3 0.0006
484 PORTAL VEIN THROMBOSIS 2 0.0006
485 URINARY TRACT INFECTION 105 0.0006
486 ASCITES 18 0.0006
487 PEPTIC ULCER 2 0.0006
488 NEPHRITIS 2 0.0006
489 TOXIC SKIN ERUPTION 6 0.0006
490 CEREBRAL HAEMATOMA 2 0.0006
491 EYELID PTOSIS 6 0.0006
492 HEPATIC CYST 2 0.0006
493 B-CELL LYMPHOMA 2 0.0006
494 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
495 APLASIA PURE RED CELL 2 0.0006
496 PERITONITIS 12 0.0006
497 GRANULOMA 2 0.0006
498 ADVERSE EVENT 53 0.0006
499 NO THERAPEUTIC RESPONSE 7 0.0006
500 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 102 0.0006
501 PRODUCT CONTAMINATION 2 0.0006
502 CONJUNCTIVAL HYPERAEMIA 2 0.0006
503 MYOSITIS 5 0.0006
504 DERMATITIS BULLOUS 4 0.0006
505 MYDRIASIS 7 0.0005
506 PRODUCT ADMINISTRATION ERROR 11 0.0005
507 GASTRIC ULCER HAEMORRHAGE 3 0.0005
508 BODY TEMPERATURE INCREASED 11 0.0005
509 MACULAR OEDEMA 3 0.0005
510 DERMATITIS CONTACT 6 0.0005
511 NEUROLOGICAL SYMPTOM 3 0.0005
512 PULMONARY FIBROSIS 10 0.0005
513 SEPSIS 58 0.0005
514 HAEMOLYSIS 4 0.0005
515 PNEUMONIA FUNGAL 2 0.0005
516 BLOOD ALBUMIN DECREASED 4 0.0005
517 POLYNEUROPATHY 6 0.0005
518 AZOTAEMIA 2 0.0005
519 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
520 TRANSPLANT REJECTION 4 0.0005
521 BLEPHARITIS 2 0.0005
522 RASH PRURITIC 27 0.0005
523 TYPE 1 DIABETES MELLITUS 3 0.0005
524 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
525 ORGAN FAILURE 2 0.0005
526 NOCTURIA 6 0.0005
527 DERMATITIS ACNEIFORM 3 0.0005
528 SMALL INTESTINAL OBSTRUCTION 6 0.0005
529 PIGMENTATION DISORDER 3 0.0005
530 HYPERBILIRUBINAEMIA 5 0.0005
531 RESPIRATORY FAILURE 35 0.0005
532 STOMATITIS 29 0.0005
533 PNEUMONITIS 13 0.0005
534 PROTEINURIA 9 0.0005
535 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
536 PURULENT DISCHARGE 2 0.0005
537 ANURIA 4 0.0005
538 METASTATIC NEOPLASM 2 0.0005
539 HEPATIC LESION 2 0.0005
540 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
541 CARDIAC FAILURE ACUTE 3 0.0004
542 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
543 INTESTINAL PERFORATION 5 0.0004
544 FISTULA 5 0.0004
545 OFF LABEL USE 386 0.0004
546 DISEASE COMPLICATION 2 0.0004
547 RENAL FAILURE 58 0.0004
548 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 8 0.0004
549 RETINAL DETACHMENT 4 0.0004
550 IRON DEFICIENCY ANAEMIA 4 0.0004
551 LOCALISED OEDEMA 2 0.0004
552 HEPATIC CIRRHOSIS 8 0.0004
553 LYMPHOPENIA 6 0.0004
554 BACTERAEMIA 5 0.0004
555 NON-SMALL CELL LUNG CANCER 2 0.0004
556 VISUAL FIELD DEFECT 3 0.0004
557 ATELECTASIS 4 0.0004
558 RASH VESICULAR 2 0.0004
559 RASH PUSTULAR 3 0.0004
560 ENCEPHALOPATHY 10 0.0004
561 CARDIOMYOPATHY 6 0.0004
562 HYPERVOLAEMIA 2 0.0004
563 HEPATOTOXICITY 9 0.0004
564 HYPERAMMONAEMIA 2 0.0004
565 DERMATITIS EXFOLIATIVE 2 0.0004
566 NEUROTOXICITY 7 0.0004
567 BLOOD CREATININE INCREASED 26 0.0004
568 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
569 AMMONIA INCREASED 2 0.0004
570 NEUROPATHY PERIPHERAL 37 0.0004
571 CEREBRAL ISCHAEMIA 2 0.0004
572 PERIPHERAL VASCULAR DISORDER 2 0.0004
573 ANOREXIA 5 0.0004
574 LEUKOCYTOSIS 7 0.0004
575 PULMONARY HAEMORRHAGE 3 0.0004
576 GASTROINTESTINAL INFLAMMATION 3 0.0004
577 PARTIAL SEIZURES 2 0.0004
578 INCONTINENCE 4 0.0004
579 PNEUMOTHORAX 6 0.0004
580 WHITE BLOOD CELL COUNT DECREASED 41 0.0004
581 RENAL CYST 3 0.0004
582 BLOOD DISORDER 3 0.0004
583 ANAL FISSURE 2 0.0004
584 BREAST CANCER METASTATIC 4 0.0004
585 URINARY INCONTINENCE 11 0.0004
586 SHOCK HAEMORRHAGIC 3 0.0004
587 DECUBITUS ULCER 3 0.0004
588 INFLAMMATION 19 0.0004
589 POLYURIA 3 0.0004
590 OESOPHAGITIS 4 0.0004
591 ESCHERICHIA INFECTION 3 0.0004
592 PLEURAL EFFUSION 22 0.0004
593 EMBOLISM 3 0.0004
594 TRANSAMINASES INCREASED 8 0.0004
595 ABDOMINAL PAIN LOWER 9 0.0004
596 SCAR 6 0.0004
597 PRODUCT CONTAINER ISSUE 3 0.0003
598 MULTI-ORGAN FAILURE 6 0.0003
599 SEPTIC SHOCK 15 0.0003
600 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
601 VASCULITIS 4 0.0003
602 HYPOVOLAEMIA 2 0.0003
603 ANAEMIA 65 0.0003
604 LABORATORY TEST ABNORMAL 10 0.0003
605 PULMONARY MASS 5 0.0003
606 IMPAIRED HEALING 11 0.0003
607 HAEMOLYTIC ANAEMIA 3 0.0003
608 BLOOD BILIRUBIN INCREASED 9 0.0003
609 HEPATITIS CHOLESTATIC 2 0.0003
610 INFECTION 48 0.0003
611 EATING DISORDER 7 0.0003
612 PLATELET COUNT DECREASED 35 0.0003
613 RESPIRATORY DEPRESSION 4 0.0003
614 RESPIRATORY DISTRESS 9 0.0003
615 RASH 142 0.0003
616 GENERALISED OEDEMA 4 0.0003
617 NEPHROPATHY 3 0.0003
618 SQUAMOUS CELL CARCINOMA 3 0.0003
619 LEUKAEMIA 3 0.0003
620 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
621 CHOLESTASIS 6 0.0003
622 ACUTE RESPIRATORY FAILURE 6 0.0003
623 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
624 MYELOSUPPRESSION 11 0.0003
625 PRODUCT PREPARATION ISSUE 2 0.0003
626 PYREXIA 105 0.0003
627 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
628 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
629 MALIGNANT MELANOMA 4 0.0003
630 RENAL IMPAIRMENT 25 0.0003
631 EMPHYSEMA 3 0.0003
632 JAUNDICE 8 0.0003
633 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
634 METASTASES TO LYMPH NODES 2 0.0003
635 POSTOPERATIVE WOUND INFECTION 2 0.0003
636 MOTOR DYSFUNCTION 3 0.0003
637 OSTEOPOROSIS 12 0.0003
638 PULMONARY OEDEMA 13 0.0003
639 LYMPHOEDEMA 2 0.0003
640 DRUG-INDUCED LIVER INJURY 9 0.0003
641 CARDIAC FAILURE 23 0.0003
642 CATARACT 17 0.0003
643 EOSINOPHILIA 5 0.0003
644 DEHYDRATION 38 0.0003
645 DRUG ERUPTION 5 0.0003
646 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
647 SINUS TACHYCARDIA 4 0.0003
648 PNEUMONIA ASPIRATION 7 0.0003
649 DECREASED APPETITE 64 0.0003
650 PELVIC PAIN 5 0.0003
651 ANGIOEDEMA 12 0.0003
652 BURNING SENSATION 19 0.0003
653 RASH PAPULAR 6 0.0003
654 BLISTER 15 0.0003
655 EYE INFECTION 3 0.0003
656 INTESTINAL OBSTRUCTION 10 0.0003
657 PEMPHIGOID 2 0.0003
658 CHILLS 31 0.0003
659 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
660 HEPATOCELLULAR CARCINOMA 2 0.0003
661 NEOPLASM 3 0.0003
662 PHARYNGEAL OEDEMA 4 0.0003
663 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
664 PERICARDIAL EFFUSION 6 0.0003
665 HYPOALBUMINAEMIA 2 0.0003
666 NERVOUS SYSTEM DISORDER 8 0.0003
667 DEVICE DISLOCATION 11 0.0003
668 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
669 ABSCESS 4 0.0003
670 DIARRHOEA 160 0.0002
671 HYPERGLYCAEMIA 9 0.0002
672 NEUTROPHIL COUNT DECREASED 10 0.0002
673 CYTOPENIA 3 0.0002
674 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
675 ABNORMAL FAECES 2 0.0002
676 OSTEONECROSIS 8 0.0002
677 HYPERCALCAEMIA 3 0.0002
678 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
679 OSTEONECROSIS OF JAW 6 0.0002
680 VOMITING 113 0.0002
681 BONE PAIN 14 0.0002
682 BLOOD UREA INCREASED 4 0.0002
683 HAEMODIALYSIS 2 0.0002
684 PERICARDITIS 4 0.0002
685 COLITIS 9 0.0002
686 MOUTH ULCERATION 5 0.0002
687 CANDIDA INFECTION 4 0.0002
688 DRY MOUTH 19 0.0002
689 ADVERSE DRUG REACTION 21 0.0002
690 ILLNESS 24 0.0002
691 SKIN ULCER 6 0.0002
692 PSYCHOLOGICAL TRAUMA 2 0.0002
693 RASH GENERALISED 6 0.0002
694 MYOPATHY 2 0.0002
695 HAEMORRHAGE 24 0.0002
696 BLOOD CALCIUM INCREASED 2 0.0002
697 ORAL CANDIDIASIS 3 0.0002
698 HYPOXIA 8 0.0002
699 LUNG INFILTRATION 2 0.0002
700 ADVERSE REACTION 3 0.0002
701 PRODUCT USE IN UNAPPROVED INDICATION 55 0.0002
702 NAUSEA 174 0.0002
703 GINGIVAL BLEEDING 3 0.0002
704 ABDOMINAL PAIN 51 0.0002
705 HEPATIC ENCEPHALOPATHY 2 0.0002
706 DEVICE OCCLUSION 3 0.0002
707 BLINDNESS UNILATERAL 3 0.0002
708 LACERATION 2 0.0002
709 CHRONIC KIDNEY DISEASE 16 0.0002
710 GASTRIC ULCER 4 0.0002
711 RED BLOOD CELL COUNT DECREASED 6 0.0002
712 RECTAL HAEMORRHAGE 9 0.0002
713 TOXICITY TO VARIOUS AGENTS 35 0.0002
714 GENERAL PHYSICAL HEALTH DETERIORATION 24 0.0002
715 KIDNEY INFECTION 4 0.0002
716 LIVER DISORDER 9 0.0002
717 SKIN EXFOLIATION 17 0.0002
718 PERITONITIS BACTERIAL 2 0.0002
719 GASTRIC CANCER 5 0.0002
720 DRUG RESISTANCE 5 0.0002
721 ANAPHYLACTIC SHOCK 5 0.0002
722 EJECTION FRACTION DECREASED 3 0.0002
723 BASAL CELL CARCINOMA 3 0.0002
724 PETECHIAE 2 0.0002
725 MUSCULOSKELETAL PAIN 10 0.0002
726 FOLLICULITIS 2 0.0002
727 PULMONARY EMBOLISM 18 0.0002
728 FULL BLOOD COUNT ABNORMAL 2 0.0002
729 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
730 HEPATIC FUNCTION ABNORMAL 7 0.0002
731 URTICARIA 31 0.0002
732 BLOOD POTASSIUM INCREASED 3 0.0002
733 ACUTE KIDNEY INJURY 28 0.0002
734 GASTROINTESTINAL PAIN 2 0.0002
735 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
736 TACHYCARDIA 16 0.0002
737 MENTAL STATUS CHANGES 5 0.0002
738 MEDICATION ERROR 10 0.0002
739 RASH MACULO-PAPULAR 4 0.0002
740 DYSPHAGIA 17 0.0002
741 MALNUTRITION 2 0.0002
742 ORAL PAIN 4 0.0002
743 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
744 IMPAIRED DRIVING ABILITY 2 0.0002
745 PRODUCT AVAILABILITY ISSUE 4 0.0002
746 MUSCULOSKELETAL DISCOMFORT 3 0.0002
747 POST PROCEDURAL HAEMORRHAGE 2 0.0002
748 LYMPHOCYTE COUNT DECREASED 3 0.0002
749 ACUTE MYOCARDIAL INFARCTION 5 0.0002
750 DISEASE RECURRENCE 8 0.0002
751 CHOLECYSTITIS 2 0.0002
752 FATIGUE 129 0.0002
753 DRUG INTOLERANCE 16 0.0002
754 BLOOD PRESSURE DECREASED 11 0.0002
755 C-REACTIVE PROTEIN INCREASED 6 0.0002
756 NEOPLASM MALIGNANT 11 0.0002
757 BONE DISORDER 3 0.0002
758 AGRANULOCYTOSIS 3 0.0002
759 PHARYNGITIS 2 0.0002
760 CYST 2 0.0002
761 EPISTAXIS 12 0.0002
762 PEMPHIGUS 2 0.0002
763 DYSPNOEA EXERTIONAL 6 0.0002
764 CELLULITIS 8 0.0002
765 HYPOPHAGIA 4 0.0002
766 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
767 ERYTHEMA 32 0.0002
768 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
769 PAIN 95 0.0002
770 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
771 BLADDER CANCER 9 0.0002
772 SKIN IRRITATION 7 0.0002
773 ANHEDONIA 4 0.0002
774 GASTRITIS 4 0.0002
775 PANCREATITIS 8 0.0002
776 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
777 HYPOTENSION 30 0.0001
778 ASTHENIA 56 0.0001
779 PRURITUS 57 0.0001
780 FREQUENT BOWEL MOVEMENTS 4 0.0001
781 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
782 ARRHYTHMIA 7 0.0001
783 ALOPECIA 29 0.0001
784 OEDEMA 8 0.0001
785 BLINDNESS 6 0.0001
786 IMPAIRED GASTRIC EMPTYING 2 0.0001
787 PRODUCTIVE COUGH 7 0.0001
788 RASH ERYTHEMATOUS 7 0.0001
789 GASTROINTESTINAL DISORDER 13 0.0001
790 TREATMENT FAILURE 12 0.0001
791 HAEMOPTYSIS 4 0.0001
792 NECK PAIN 8 0.0001
793 HYPERKALAEMIA 5 0.0001
794 IMPAIRED WORK ABILITY 3 0.0001
795 BRONCHOSPASM 2 0.0001
796 SYNCOPE 14 0.0001
797 ANGINA PECTORIS 4 0.0001
798 DEEP VEIN THROMBOSIS 9 0.0001
799 HYPOKINESIA 2 0.0001
800 GASTROENTERITIS 2 0.0001
801 THROMBOSIS 11 0.0001
802 BRONCHITIS 10 0.0001
803 TOOTH DISORDER 3 0.0001
804 HYPERSENSITIVITY 25 0.0001
805 ATRIAL FIBRILLATION 13 0.0001
806 BACK PAIN 31 0.0001
807 HYPERTENSION 28 0.0001
808 ECONOMIC PROBLEM 2 0.0001
809 OEDEMA PERIPHERAL 16 0.0001
810 NEPHROLITHIASIS 6 0.0001
811 FEELING HOT 8 0.0001
812 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
813 HOSPITALISATION 20 0.0001
814 DEVICE RELATED INFECTION 2 0.0001
815 BREAST CANCER 12 0.0001
816 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
817 CYANOSIS 2 0.0001
818 ANAPHYLACTIC REACTION 7 0.0001
819 HAEMOGLOBIN DECREASED 13 0.0001
820 METABOLIC ACIDOSIS 4 0.0001
821 CONSTIPATION 27 0.0001
822 PRESYNCOPE 3 0.0001
823 DYSGEUSIA 9 0.0001
824 AGEUSIA 3 0.0001
825 DYSPNOEA 68 0.0001
826 SKIN DISORDER 4 0.0001
827 INCORRECT DOSE ADMINISTERED 27 0.0001
828 CARDIOVASCULAR DISORDER 3 0.0001
829 CIRCULATORY COLLAPSE 2 0.0001
830 HEPATITIS 3 0.0001
831 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
832 DIPLOPIA 3 0.0001
833 RESPIRATORY TRACT INFECTION 3 0.0001
834 RASH MACULAR 4 0.0001
835 CHEST PAIN 21 0.0001
836 GALLBLADDER DISORDER 2 0.0001
837 THERAPY NON-RESPONDER 5 0.0001
838 DEATH 94 0.0001
839 CARDIAC ARREST 9 0.0001
840 AGITATION 8 0.0001
841 SWELLING 10 0.0001
842 BLOOD SODIUM DECREASED 2 0.0001
843 PAIN IN JAW 3 0.0001
844 HYPOCALCAEMIA 2 0.0001
845 DIABETES MELLITUS 8 0.0001
846 LETHARGY 6 0.0001
847 EYE IRRITATION 6 0.0001
848 GLAUCOMA 2 0.0001
849 LIVER FUNCTION TEST ABNORMAL 3 0.0001
850 HAEMATOCRIT DECREASED 2 0.0001
851 DRY EYE 5 0.0001
852 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
853 CONDITION AGGRAVATED 30 0.0001
854 DISCOMFORT 6 0.0001
855 PRODUCT PREPARATION ERROR 2 0.0001
856 SWOLLEN TONGUE 3 0.0001
857 MALAISE 42 0.0001
858 SPEECH DISORDER 5 0.0001
859 BRADYCARDIA 5 0.0001
860 RENAL FAILURE ACUTE 4 0.0001
861 LIVER FUNCTION TEST INCREASED 2 0.0001
862 NIGHT SWEATS 3 0.0001
863 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
864 FAECES DISCOLOURED 2 0.0001
865 CHOLELITHIASIS 3 0.0001
866 INFUSION RELATED REACTION 6 0.0001
867 EXPIRED PRODUCT ADMINISTERED 3 0.0001
868 BLOOD GLUCOSE INCREASED 17 0.0001
869 PARAESTHESIA 14 0.0001
870 PANCREATITIS ACUTE 2 0.0001
871 OXYGEN SATURATION DECREASED 5 0.0001
872 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
873 CHROMATURIA 2 0.0001
874 HEPATIC ENZYME INCREASED 6 0.0001
875 DRUG INEFFECTIVE 115 0.0001
876 CARDIAC FAILURE CONGESTIVE 7 0.0001
877 SKIN DISCOLOURATION 4 0.0001
878 PNEUMONIA 28 0.0001
879 DELIRIUM 3 0.0001
880 MYOCARDIAL INFARCTION 15 0.0001
881 PRODUCT USE ISSUE 16 0.0001
882 OCULAR HYPERAEMIA 4 0.0001
883 CEREBRAL HAEMORRHAGE 3 0.0001
884 SKIN BURNING SENSATION 6 0.0001
885 DIABETIC KETOACIDOSIS 2 0.0001
886 THERAPEUTIC RESPONSE DECREASED 5 0.0001
887 WEIGHT DECREASED 23 0.0001
888 EYE SWELLING 3 0.0001
889 CONFUSIONAL STATE 13 0.0001
890 MUSCULAR WEAKNESS 9 0.0001
891 HAEMATEMESIS 2 0.0001
892 SWELLING FACE 5 0.0001
893 ABDOMINAL DISTENSION 8 0.0001
894 DEAFNESS 2 0.0001
895 ECZEMA 4 0.0001
896 CARDIAC DISORDER 7 0.0001
897 DEVICE BREAKAGE 3 0.0001
898 PALLOR 2 0.0001
899 PROCEDURAL PAIN 2 0.0001
900 ARTHROPATHY 4 0.0001
901 HYPONATRAEMIA 4 0.0001
902 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
903 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
904 CONVULSION 4 0.0001
905 FLUSHING 7 0.0001
906 COVID-19 12 0.0001
907 SURGERY 4 0.0001
908 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
909 WHEEZING 4 0.0001
910 HYPOAESTHESIA 10 0.0001
911 BLOOD POTASSIUM DECREASED 2 0.0001
912 LACRIMATION INCREASED 2 0.0001
913 CORONARY ARTERY DISEASE 2 0.0001
914 HYPOKALAEMIA 3 0.0001
915 RENAL DISORDER 3 0.0001
916 RENAL CANCER 3 0.0001
917 INFLUENZA 7 0.0001
918 HYPOGLYCAEMIA 3 0.0001
919 LUNG DISORDER 3 0.0001
920 EYE DISORDER 2 0.0001
921 INFLUENZA LIKE ILLNESS 5 0.0001
922 MYALGIA 10 0.0001
923 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
924 VISION BLURRED 8 0.0001
925 ARTHRALGIA 24 0.0001
926 COUGH 16 0.0001
927 INJURY 4 0.0001
928 LYMPHADENOPATHY 2 0.0001
929 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
930 DRUG EFFECT DECREASED 3 0.0001
931 ACCIDENTAL OVERDOSE 2 0.0001
932 HAEMATOCHEZIA 3 0.0001
933 HYPERHIDROSIS 7 0.0001
934 OROPHARYNGEAL PAIN 5 0.0001
935 ABDOMINAL DISCOMFORT 9 0.0001
936 ABDOMINAL PAIN UPPER 11 0.0001
937 DYSPHONIA 3 0.0001
938 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
939 VERTIGO 3 0.0000
940 INSOMNIA 13 0.0000
941 LUNG NEOPLASM MALIGNANT 2 0.0000
942 CARDIO-RESPIRATORY ARREST 2 0.0000
943 OSTEOARTHRITIS 2 0.0000
944 BALANCE DISORDER 4 0.0000
945 DEVICE LEAKAGE 2 0.0000
946 DIZZINESS 23 0.0000
947 MENTAL DISORDER 2 0.0000
948 BLOOD PRESSURE INCREASED 7 0.0000
949 FALL 15 0.0000
950 COLITIS ULCERATIVE 2 0.0000
951 SOMNOLENCE 9 0.0000
952 PALPITATIONS 5 0.0000
953 DEVICE MALFUNCTION 3 0.0000
954 SLEEP DISORDER 3 0.0000
955 TREMOR 7 0.0000
956 COMA 2 0.0000
957 EMOTIONAL DISTRESS 5 0.0000
958 PAIN IN EXTREMITY 12 0.0000
959 HEADACHE 25 0.0000
960 DRUG INTERACTION 6 0.0000
961 FEELING ABNORMAL 9 0.0000
962 DISTURBANCE IN ATTENTION 2 0.0000
963 PRODUCT QUALITY ISSUE 5 0.0000
964 EYE PAIN 2 0.0000
965 CEREBROVASCULAR ACCIDENT 6 0.0000
966 FLATULENCE 2 0.0000
967 HERPES ZOSTER 2 0.0000
968 SEIZURE 4 0.0000
969 PRODUCT STORAGE ERROR 3 0.0000
970 MUSCULOSKELETAL STIFFNESS 3 0.0000
971 IRRITABILITY 2 0.0000
972 VISUAL IMPAIRMENT 4 0.0000
973 GAIT DISTURBANCE 6 0.0000
974 LOSS OF CONSCIOUSNESS 4 0.0000
975 CONTUSION 3 0.0000
976 DEPRESSION 7 0.0000
977 AMNESIA 2 0.0000
978 DYSPEPSIA 3 0.0000
979 HEART RATE INCREASED 3 0.0000
980 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
981 OVERDOSE 6 0.0000
982 MUSCLE SPASMS 5 0.0000
983 HOT FLUSH 2 0.0000
984 ARTHRITIS 2 0.0000
985 ANXIETY 7 0.0000
986 MIGRAINE 2 0.0000
987 CHEST DISCOMFORT 2 0.0000
988 PERIPHERAL SWELLING 3 0.0000
989 NO ADVERSE EVENT 3 0.0000
990 PRODUCT DOSE OMISSION ISSUE 4 0.0000
991 WEIGHT INCREASED 3 0.0000
992 DRUG DOSE OMISSION 2 0.0000
993 NASOPHARYNGITIS 2 0.0000